Home / Pharmacology / Central Nervous System

Tricyclic Antidepressant (TCA) Overdose: Biochemical Pathways (Professor's Commentary Supplement)

Central Nervous System Specialty Division
â–  LECTURE OVERVIEW: Tricyclic Antidepressant (TCA) overdose is a major toxicological emergency characterized by multi-system receptors blockade. â–  THE CARDIOVASCULAR AND CENTRAL TOXICITIES: 1. Rapid Cardiac Sodium Channel Inactivation: TCAs block fast sodium channels (IKr) in myocardial tissue, slowing Phase 0 of the action potential and prolonging the QRS interval. This drives severe intraventricular conduction delays and lethal ventricular arrhythmias. 2. Anticholinergic Overdrive: Blocks muscarinic (M1) receptors, producing central and peripheral anticholinergic syndrome (altered mental status, dry skin, dilated non-reactive pupils, urinary retention, and hyperthermia). 3. Vascular Collapse: Inhibits alpha-1 adrenergic receptors, preventing peripheral vasoconstriction and causing refractory hypotension. 4. Neuronal Excitability: Blocks GABA-A receptors in the brain, lowering the seizure threshold and precipitating status epilepticus. â–  BIOCHEMICAL MECHANISMS: At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly. â–  PROFESSOR'S CRITICAL SYNTHESIS: Understanding the transition point from reversible cell injury to irreversible cellular death is the most fundamental concept in clinical medicine. [HY-BOARD-1310]

🌟 Dynamic Clinical Key:

First-line, life-saving treatment is intravenous Sodium Bicarbonate (NaHCO3). The sodium load increases extracellular sodium concentration to overcome the TCA-mediated blockade, while the systemic alkalorization (raising pH to 7.45-7.55) converts the TCA molecule into its neutral, non-ionized form, reducing its affinity for sodium channels. Focus on rate-limiting regulatory steps for pharmacological design. Connect microscopic cellular structure with patient presentation to develop a unified diagnostic vision.

Professional Medical Reference Application v2.5

For training, board examinations (USMLE, PLAB), and clinician benchmarking. Do not replace professional care.